Amy Egan
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Drug-Induced Adverse Reactions 1
- Pharmacology and Obesity Treatment 1
-
- Malaria Research and Control 2
- Co-authors
- Curtis J. Rosebraugh (2 shared papers)Eric Colman (2 shared papers)E. Blind (1 shared paper)Kristina Dunder (1 shared paper)T. Bourcier (1 shared paper)B. Timothy Hummer (1 shared paper)Julie K. Golden (1 shared paper)Joyce Weaver (1 shared paper)
- Journals
- New England Journal of Medicine (3 papers)Parasitology (1 paper)Injury Prevention (1 paper)Molecular Biology and Evolution (1 paper)Genome Research (1 paper)
- Partner nations
- United StatesNetherlandsThailand
In The Last Decade
Amy Egan
8 papers receiving 789 citations
Amy Egan's Hit Papers
Peers
Comparison fields: 5 of 90
- Endocrinology, Diabetes and Metabolism 366
- Pharmacology 154
- Parasitology 37
- Surgery 188
- Physical Therapy, Sports Therapy and Rehabilitation 19
Countries citing papers authored by Amy Egan
This map shows the geographic impact of Amy Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Egan more than expected).
Fields of papers citing papers by Amy Egan
This network shows the impact of papers produced by Amy Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Egan. The network helps show where Amy Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment Hit paper breakdown → | 2014 | 375 |
| 2 | 2012 | 140 | |
| 3 | 2004 | 108 | |
| 4 | 2011 | 85 | |
| 5 | 2010 | 40 | |
| 6 | 2019 | 40 | |
| 7 | 2015 | 31 | |
| 8 | 2019 | 1 |
About Amy Egan
Amy Egan is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Surgery, Molecular Biology and Genetics, having authored 8 papers that have together received 820 indexed citations. Recurring topics across this work include Malaria Research and Control (2 papers), Genetic diversity and population structure (1 paper), Diet and metabolism studies (1 paper), Chromosomal and Genetic Variations (1 paper), Balance, Gait, and Falls Prevention (1 paper), Drug-Induced Adverse Reactions (1 paper), Pharmacology and Obesity Treatment (1 paper) and Chemotherapy-related skin toxicity (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (366 citations), Pharmacology (154 citations), Parasitology (37 citations), Surgery (188 citations) and Physical Therapy, Sports Therapy and Rehabilitation (19 citations). Amy Egan has collaborated with scholars based in United States, Netherlands and Thailand. Frequent co-authors include Curtis J. Rosebraugh, Eric Colman, E. Blind, Kristina Dunder, T. Bourcier, B. Timothy Hummer, Julie K. Golden, Joyce Weaver, Rui Chen and Xingzhi Song. Their work appears in journals such as New England Journal of Medicine, Parasitology, Injury Prevention, Molecular Biology and Evolution and Genome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.